US powerhouse Davis Polk & Wardwell LLP continues to pick up a strong pipeline of work for Chinese issuers from a range of sectors including healthcare and TMT on their offshore IPOs, global offerings and follow-on offerings. Due to its US heritage and the presence of many US-qualified partners in Hong Kong, the team has historically been active advising Chinese companies list on the Nasdaq. Although this source of work was substantially impacted by geo-political tensions, in a rare US IPO the firm successfully advised Atour Lifestyle Holdings Limited on its $52m listing of American Depositary Shares (ADS’s) on the Nasdaq. Li He led on the aforementioned deal and is as comfortable handling US IPOs as he is handling listings on the HKEX. Other recommended partners include the vastly experienced James Lin and Yang Chu , who regularly handles IPOs, follow-on offerings and share placements in the biotech sector.
Key clients
- ZJLD Group
- MedSci Healthcare
Work highlights
- Advising ZJLD Group on its HK$5.3bn IPO and listing on the Hong Kong Stock Exchange.
- Advising Atour Lifestyle Holdings on its $52m IPO of ADSs and Nasdaq listing.